Meal timing strategies can be represented as a PK→PD modeling construct in which pre-meal, post-meal, or intra-meal dosing changes dissolution timing, gastric emptying, and early absorption geometry. A pre-meal parameter set can represent earlier gastric transit and a steeper rising-phase input, whereas a post-meal set can represent delayed dissolution and a flatter absorption slope. An intra-meal set can represent an intermediate or composition-dependent combination of these geometric features. These are mechanistic parameter configurations rather than clinical outcomes, and they describe how the same sildenafil molecule can occupy different modeled concentration-time trajectories. Because dissolution and early input are coupled to upper gastrointestinal transit, changing the timing of food relative to dosing can alter when absorbed drug begins contributing materially to the rising phase. Meal timing therefore changes rising-phase geometry and threshold-region entry timing while leaving molecular identity unchanged. The resulting interpretation is strictly PK→PD, with timing differences expressed as changes in model parameters.
PK determinants shape meal-timing-modified onset by controlling when input enters the systemic compartment and how rapidly concentration rises. Dissolution timing establishes when sildenafil becomes available for absorption, while gastric emptying controls the transit interval before that availability can contribute to systemic input. Absorption geometry then determines the slope, curvature, and timing of the rising concentration phase. A pre-meal parameter set can represent a shorter transit delay and steeper input geometry, shifting modeled threshold-region entry earlier. A post-meal parameter set can represent a longer delay and flatter input geometry, shifting entry later. An intra-meal configuration can place these parameters between those states or represent a distinct combined geometry. Distribution kinetics and metabolic turnover operate concurrently, shaping the observed concentration trajectory as absorption proceeds. Tmax and Cmax describe peak position and magnitude, respectively, but neither parameter alone defines modeled onset. Thus, meal timing modifies onset primarily through input geometry and its interaction with disposition parameters.
PD mapping determines how a meal-timing-modified concentration trajectory is translated into modeled onset once concentration approaches a defined threshold region. A PD threshold can be treated as a concentration-effect coordinate within the model, while coupling parameters determine how concentration is mapped onto effect. Identical PK trajectories can therefore intersect differently positioned threshold regions when PD parameter sets vary. Conversely, identical PD mapping can yield different threshold-entry times when meal timing changes dissolution, transit, and absorption geometry. The resulting timing difference is a geometric property of the combined PK→PD system rather than a clinical comparison. Meal timing can thus be represented as a perturbation of the input trajectory, followed by distribution, metabolic turnover, and concentration-effect mapping. The onset coordinate emerges where the resulting trajectory enters the specified PD region. Duration and onset remain distinct dimensions because threshold entry depends on the rising phase, whereas persistence depends on the subsequent concentration decline and PD mapping. This framework isolates mechanism without outcome interpretation.
Meal timing changes the modeled relationship between gastrointestinal transit and systemic input. In a pre-meal parameter set, gastric emptying can be represented as a shorter transit interval, allowing dissolved sildenafil to reach the absorption region earlier and producing a steeper early input curve. A post-meal parameter set can represent prolonged gastric residence, delaying the appearance of absorbable drug and flattening the initial slope. An intra-meal configuration can encode a combined transit and dissolution geometry that falls between, overlaps, or differs from those two simplified states. The key variable is not the meal label itself but the parameter set assigned to dissolution and transit. As these parameters change, the absorption-rate profile changes its timing and curvature. The resulting systemic concentration curve can therefore reach a defined concentration region at different coordinates even when dose and molecular properties remain fixed. This mechanism is represented through transit and input functions rather than clinical interpretation.
Distribution and metabolic turnover continue operating while meal-timing-modified absorption supplies systemic input. A steeper early absorption function can temporarily dominate the concentration trajectory, whereas a delayed or flatter input function gives distribution and elimination more time to act before peak formation. Distribution kinetics determine how rapidly newly absorbed sildenafil moves between modeled compartments, while metabolic turnover controls the concurrent removal process. These parameters can therefore alter the height, curvature, and persistence of trajectories generated from different meal-timing inputs. The same dissolution delay can produce different concentration profiles when distribution or metabolic parameters are changed. In mechanistic terms, meal timing modifies the input function, while disposition parameters determine how that input is transformed after entering the systemic model. Peak coordinates and declining-phase behavior consequently depend on the interaction between absorption, distribution, and metabolic turnover. The interpretation remains a parameter-set comparison, with no need to assign a clinical meaning to any trajectory.
| PK Domain | Mechanistic Determinant | Link |
|---|---|---|
| Gastric Emptying | Transit timing. | gastric emptying |
| Absorption | Rising-phase geometry. | absorption curves |
| Distribution & Metabolism | Early disposition. | pk variability |
A PD threshold defines a modeled concentration region at which the concentration-effect mapping enters a specified response domain. When meal timing changes the PK trajectory, the time at which that trajectory intersects the threshold can shift even if the threshold itself is unchanged. A steeper rising curve reaches the same threshold coordinate sooner than a flatter curve, while a delayed absorption function moves the intersection later. This makes threshold-region entry a useful geometric representation of onset. The threshold is a model parameter rather than a clinical recommendation, and its placement determines how much concentration development is required before the modeled transition occurs. Meal timing therefore affects onset indirectly by changing the PK path that approaches the PD boundary. Distribution and metabolic turnover can further reshape that path before intersection. The resulting onset coordinate is determined by the combined concentration trajectory and threshold placement, not by meal timing as an isolated variable.
PD variability changes how the same meal-timing-modified PK trajectory is mapped onto a threshold region. If two parameter sets use identical dissolution, gastric-emptying, absorption, distribution, and metabolic functions but different concentration-effect relationships, the threshold coordinate can be reached at different times. Conversely, changing meal timing while holding PD parameters constant shifts the PK trajectory relative to the same threshold. This separation allows meal timing to be modeled independently from PD coupling. Threshold placement determines the concentration coordinate required for entry, while the PK trajectory determines when that coordinate is reached. Changes in coupling slope or other PD parameters can alter the geometry of the concentration-effect relationship without changing the underlying absorption curve. The resulting onset difference is therefore an emergent property of two parameter domains: meal-timing-sensitive PK input and PD mapping. This framework distinguishes changes caused by concentration development from changes caused by the concentration-effect transformation itself.
| PD Domain | Mechanistic Determinant | Link |
|---|---|---|
| Threshold Mapping | Concentration–effect coupling. | pd variability |
| PD Variability | Timing differences. | pkpd summary |
Meal-timing-modified onset geometry is determined by the shape and timing of the modeled concentration trajectory. Dissolution timing establishes when available drug enters the absorption process, gastric emptying controls transit to the absorption region, and absorption parameters determine the rate and curvature of systemic input. Distribution and metabolic turnover then transform that input into the observed concentration profile. A pre-meal parameter set can produce an earlier, steeper rising trajectory, while a post-meal set can produce a delayed, flatter trajectory; an intra-meal set can represent another defined geometry. Onset is modeled at the intersection between these trajectories and a specified PD threshold. Thus, the same dose can generate different onset coordinates solely because the parameter set describing food-relative timing has changed. The geometry can be visualized as a family of concentration-time curves sharing molecular identity but differing in transit and input timing. No clinical outcome is required to describe these modeled differences.
PK parameters determine how food-relative timing is translated into an absorption curve. Dissolution timing specifies when the solid or formulated input becomes available, gastric-emptying parameters determine transit timing, and absorption-rate parameters control the slope and curvature of systemic appearance. A delayed gastric-emptying parameter can shift the entire rising phase later, while a lower effective absorption-rate parameter can flatten the rise after transit has occurred. Distribution and metabolic turnover modify the resulting concentration profile once systemic input begins. These parameters can interact, so the same transit delay does not necessarily create the same peak or threshold-entry coordinate across different disposition settings. Tmax identifies the modeled time of maximum concentration, while Cmax identifies the modeled peak magnitude; both are descriptive coordinates rather than direct definitions of onset. Meal timing is therefore represented as a structured perturbation of input and disposition parameters, allowing pre-meal, intra-meal, and post-meal trajectories to be compared through their geometry without assigning clinical meaning to the curves.
Sildenafil and tadalafil can be represented with different meal-timing-sensitive PK→PD parameter sets because their absorption, disposition, and food-response structures are not identical. In a mechanistic comparison, sildenafil can be assigned one dissolution, transit, absorption, distribution, and metabolic parameter configuration, while tadalafil is assigned another. The resulting concentration-time curves can therefore differ in rising-phase slope, peak position, and decline geometry when food-relative timing is changed. A PD layer can then map each compound-specific trajectory onto its own threshold or concentration-effect parameters. This does not require a clinical interpretation; it describes how distinct molecular systems can occupy different regions of PK→PD parameter space. Meal timing becomes a controlled input perturbation applied separately to each compound model. Differences in modeled onset or duration then arise from the specified parameter values and their interactions, rather than from the meal label itself. The comparison is consequently a geometric analysis of compound-specific absorption and disposition structures.
| Balance Domain | Mechanistic Determinant | Link |
|---|---|---|
| PK Trajectory | Exposure development. | speed profiles |
| PD Mapping | Threshold placement. | onset difference |
| PK→PD Balance | Combined geometry. | food effects comparison |
Meal timing modifies the modeled onset geometry by changing parameters that govern dissolution timing, gastric emptying, and early absorption. A pre-meal parameter set can represent earlier transit and a steeper rising concentration curve, whereas a post-meal set can represent delayed transit and a flatter rising curve. An intra-meal parameter set can encode another defined combination of transit and input characteristics. Once these PK trajectories are generated, a PD threshold maps concentration development onto an onset coordinate. The threshold itself can remain fixed while the concentration trajectory shifts relative to it. Distribution kinetics and metabolic turnover further shape the trajectory during this interval. Consequently, modeled onset changes because the path through concentration-time space changes, not because meal timing is treated as an independent effect variable. The framework is strictly mechanistic: meal timing modifies PK parameterization, and PK→PD coupling converts that trajectory into a defined geometric threshold-entry time.
PK parameters determine how meal-relative timing becomes a concentration-time trajectory. Dissolution timing controls when sildenafil becomes available for absorption, while gastric-emptying parameters determine when that material reaches the modeled absorption region. Absorption-rate parameters then determine the slope and curvature of systemic input. A shorter transit interval combined with a faster input function produces an earlier and steeper rising phase, while longer transit or slower input parameters shift and flatten that phase. Distribution kinetics subsequently determine how absorbed drug moves through modeled compartments, and metabolic turnover determines concurrent removal. These processes operate together, so a change in one parameter can alter the effect of another on the resulting curve. Tmax and Cmax describe peak geometry but do not independently establish onset. Meal timing is therefore encoded as a change in PK parameter values, allowing pre-meal, intra-meal, and post-meal configurations to generate distinct absorption and disposition trajectories.
PD parameters influence modeled onset by determining how a concentration trajectory is translated into a concentration-effect coordinate. A threshold parameter establishes the concentration region associated with the modeled transition, while coupling parameters determine the relationship between concentration and the mapped effect domain. If the same rising PK trajectory encounters a lower threshold, the intersection occurs earlier; a higher threshold produces a later intersection. Changes in coupling can also modify the relationship without altering dissolution, gastric emptying, or absorption. Meal timing therefore acts primarily through the PK trajectory, while PD parameters determine how that trajectory is interpreted at the threshold boundary. Distribution and metabolic turnover remain part of the PK side and can change when the boundary is reached. The resulting onset coordinate is consequently determined by the interaction between meal-timing-specific concentration development and PD mapping. This separates gastrointestinal timing parameters from concentration-effect parameters within the overall PK→PD model.
Sildenafil and tadalafil can be represented using different PK→PD parameter sets because their compound-specific absorption and disposition structures are distinct. In a mechanistic model, each compound can have its own dissolution, gastric-emptying sensitivity, absorption-rate, distribution, and metabolic-turnover parameters. Applying pre-meal, intra-meal, or post-meal conditions can therefore generate different concentration-time geometries for each compound. The rising phase, peak position, and declining phase can change according to the parameter values assigned to each system. A PD mapping layer can then translate each concentration trajectory into a threshold-entry coordinate using compound-specific concentration-effect parameters. The comparison is consequently based on differences between parameterized trajectories rather than on a general meal label. Any modeled timing difference follows from the specified absorption, disposition, and PD coupling functions. This approach keeps the analysis within PK and PD geometry and does not require statements about subjective effects, clinical effectiveness, or patient outcomes.
Meal timing represents one structured source of onset variability because it can change the parameters governing dissolution, gastric emptying, and absorption geometry. Different parameter sets can shift the rising concentration curve horizontally, alter its slope, or change its curvature. When the resulting curves are evaluated against the same PD threshold, their intersection times can differ. This mechanism is distinct from PD variability, where the threshold or concentration-effect mapping changes while the PK trajectory may remain unchanged. A complete model can include both simultaneously, producing multiple PK→PD trajectories with different threshold-entry coordinates. The variability is therefore a mathematical consequence of parameter changes rather than an independent outcome variable. Pre-meal, intra-meal, and post-meal configurations can be treated as defined input states within the model, while distribution and metabolic turnover transform each input after systemic entry. The resulting onset differences describe geometric relationships among parameters, concentration trajectories, and thresholds without requiring clinical interpretation.